$3.00
0.020.67%
At close: -
$2.80
-0.20-6.67%
After Hours: Dec 19, 9:24 AM EDT
Comments
Loading...
InspireMD (NASDAQ:NSPR) Stock, Analyst Ratings, Price Targets, Forecasts
InspireMD Inc has a consensus price target of $4.85 based on the ratings of 4 analysts. The high is $5.15 issued by Alliance Global Partners on March 31, 2023. The low is $4.5 issued by Piper Sandler on September 17, 2024. The 3 most-recent analyst ratings were released by Lake Street, Piper Sandler, and Piper Sandler on December 11, 2024, September 17, 2024, and November 2, 2023, respectively. With an average price target of $4.67 between Lake Street, Piper Sandler, and Piper Sandler, there's an implied 66.67% upside for InspireMD Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Lake Street
Piper Sandler
National Alliance Securities
Alliance Global Partners
1calculated from analyst ratings
Analyst Ratings for InspireMD
Data brought to you by Benzinga APIs
FAQ
What is the target price for InspireMD (NSPR) stock?
The latest price target for InspireMD (NASDAQ:NSPR) was reported by Lake Street on December 11, 2024. The analyst firm set a price target for $5.00 expecting NSPR to rise to within 12 months (a possible 78.57% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for InspireMD (NSPR)?
The latest analyst rating for InspireMD (NASDAQ:NSPR) was provided by Lake Street, and InspireMD initiated their buy rating.
When was the last upgrade for InspireMD (NSPR)?
There is no last upgrade for InspireMD
When was the last downgrade for InspireMD (NSPR)?
There is no last downgrade for InspireMD.
When is the next analyst rating going to be posted or updated for InspireMD (NSPR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of InspireMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for InspireMD was filed on December 11, 2024 so you should expect the next rating to be made available sometime around December 11, 2025.
Is the Analyst Rating InspireMD (NSPR) correct?
While ratings are subjective and will change, the latest InspireMD (NSPR) rating was a initiated with a price target of $0.00 to $5.00. The current price InspireMD (NSPR) is trading at is $2.80, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.